Advertisement
Organisation › Details
BioFire Diagnostics Inc.
Idaho Technology, Inc. is a privately held biotechnology company based in Salt Lake City, Utah. Founded in 1990, Idaho Technology licensed the rapid PCR technology from the University of Utah. Through funds from the United States Department of Health and Human Services and the Department of Defense, the company has created many commercial instruments and reagents for use in research and applied fields. Several of these products, including the LightCyclerR Instrument, have been sublicensed to Roche Diagnostics. Researchers, medical technicians, law enforcement officers, and soldiers in the field use the company's devices to detect or study disease-causing organisms. *
Start | 2012-08-28 renamed | |
End | 2014-01-16 renamed data ca. | |
Group | Mérieux (Group) | |
Today | BioFire Diagnostics LLC | |
Predecessor | Idaho Technology Inc. (ITI) | |
Successor | BioFire Diagnostics LLC | |
Industry | PCR technology | |
Industry 2 | molecular diagnostics | |
Person | Ririe, Kirk (BioFire Diagnostics 201309 CEO + Founder) | |
Region | Salt Lake City, UT | |
Country | United States (USA) | |
Street | 390 Wakara Way | |
City | 84108 Salt Lake City, UT | |
Tel | +1-801-736-6354 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | D: 101 to 500 (2013-09-03) |
Currency | USD | |
Annual sales | 70,000,000 (sales (2013, fiscal) 2013-09-30) | |
* Document for »About Section«: | ||
Record changed: 2020-11-02 |
Advertisement
More documents for Mérieux (Group)
- [1] Transgene S.A.. (1/22/24). "Press Release: Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer". Strasbourg....
- [2] bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile....
- [3] Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford....
- [4] Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg....
- [5] bioMérieux S.A.. (4/14/23). "Press Release: Oxford Nanopore and bioMérieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics". Oxford & Marcy-l’Etoile....
- [6] ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon....
- [7] InDevR, Inc.. (1/17/23). "Press Release: InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux". Boulder, CO....
- [8] Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg....
- [9] Mablink Bioscience S.A.S.. (10/14/22). "Press Release: Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners". Lyon....
- [10] Weezion S.A.S.. (6/1/22). "Press Release: Weezion, a French MedTech Start-up, Announces Capital Investment from bioMérieux". Lyon....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top